Instrument Inactif

Communiqués BioLargo, Inc. Other OTC

Actions

BLGO

US09065A1007

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

BioLargo to Present at The LD Micro Invitational XIV	25/03	NE
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready	22/02	AQ
BioLargo, Inc. to Present at the LD Micro Main Event XVI	19/09/23	NE
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast	05/06/23	NE
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	18/05/23	AQ
0:00:05.7 Dennis Calvert: Today. What's up? Dennis Calvert - Form 8-K	09/05/23	PU
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	09/05/23	AQ
BioLargo to Present at the Sequire Investor Summit in Puerto Rico	24/04/23	AQ
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	04/04/23	AQ
BIOLARGO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/23	AQ
BioLargo, Inc. Discusses 125% Revenue Increase and Significance of Proposed EPA PFAS Regulations with The Stock Day Podcast	29/03/23	NE
BIOLARGO, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	27/03/23	AQ
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20/03/23	AQ
BioLargo, Inc. Discusses 125% Revenue Increase for 2022 with The Stock Day Podcast	31/01/23	NE
BIOLARGO, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	19/12/22	AQ
BIOLARGO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22	AQ
BioLargo : Adds Linda Park and Christina Bray to Board of Directors - Form 8-K	03/11/22	PU
BIOLARGO, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	03/11/22	AQ
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	31/10/22	AQ
BioLargo, Inc. Discusses Its PFAS Treatment Solution and Odor Control Technology with The Stock Day Podcast	25/10/22	NE

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués BioLargo, Inc. Other OTC

Actions

BLGO

US09065A1007

Communiqués

Filtres